Skip to content

Author

Bo Li

We have 2 of 7 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Sep 2026

Targeting the choroidal neovascularization microenvironment: new perspectives in nanotherapeutic strategies.

Choroidal neovascularization (CNV) is a key pathological mechanism underlying irreversible vision loss in diseases such as age-related macular degeneration (AMD). Although anti-vascular endothelial growth factor (VEGF) therapies effectively inhibit angiogenesis, they are limited by the need for frequent injections, the...

Xiao-Yan Lu, Bo Li, Bao-Yuan Sun et al. · 0 citations
Review Aug 2026

[Advances in stem cell and exosome-based therapies for dry eye disease].

This review summarizes recent advances in stem cell and exosome-based treatments for dry eye disease and analyzes their current regulatory landscapes, intending to serve as a reference for investigators within the field.

Hua-Teng Zhang, Lei-Qing Wang, Chao Lin et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.